- Core Laboratories Inc. reported a 1% increase in revenue in Q1 2024 compared to Q4 2023. - The company's operating income for Q1 2024 was $14.9 million, with operating margins at 12%. - US land completion activity was down 11% in Q1 2024, but U.S. completion diagnostic services and product sales saw growth. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
- CLB reported adjusted earnings of 19 cents per share, beating estimates due to Reservoir Description performance. - Operating revenues of $129.6 million exceeded estimates by 4.5%, increasing from the year-ago quarter. - Reservoir Description segment saw revenue increase by 5%, while Production Enhancement segment revenue decreased. - CLB's outlook for Q2 2024 includes revenues of $130-$136 million with EPS between 19-23 cents. - CLB's board approved a quarterly dividend of a cent per share on common stock. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Corporate Developments